The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.
Open accessAbstract
Cells with a functional p53 pathway undergo a G0/G1 arrest or apoptosis when treated with gamma radiation or many chemotherapeutic drugs. It has been proposed that DNA damage is the exclusive signal that triggers the arrest response. However, we found that certain ribonucleotide biosynthesis inhibitors caused a p53-dependent G0 or early G1 arrest in the absence of replicative DNA synthesis or detectable DNA damage in normal human fibroblasts. CTP, GTP, or UTP depletion alone was sufficient to induce arrest. In contrast to the p53-dependent response to DNA damage, characterized by long-term arrest and irregular cellular morphologies, the antimetabolite-induced arrest was highly reversible and cellular morphologies remained relatively normal. Both arrest responses correlated with prolonged induction of p53 and the Cdk inhibitor P21(WAF1/CIP1/SDI1) and with dephosphorylation of pRb. Thus, we propose that p53 can serve as a metabolite sensor activated by depletion of ribonucleotides or products or processes dependent on ribonucleotides. Accordingly, p53 may play a role in inducing a quiescence-like arrest state in response to nutrient challenge and a senescence-like arrest state in response to DNA damage. These results have important implications for the mechanisms by which p53 prevents the emergence of genetic variants and for developing more effective approaches to chemotherapy based on genotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Self-citationYin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Self-citationNelson, W. G., & Kastan, M. B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1815 · Cited by 857
Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate
Santi, D. V., McHenry, C. S., & Sommer, H. (1974) · Biochemistry · doi:10.1021/bi00700a012 · Cited by 619
Control of the yeast cell cycle by the Cdc28 protein kinase
Nasmyth, K. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90099-c · Cited by 486
Role for Ceramide in Cell Cycle Arrest
Jayadev, S., Liu, B., Bielawska, A. E., Lee, J. Y., Nazaire, F., Pushkareva, M. Y., Obeid, L. M., & Hannun, Y. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2047 · Cited by 486
Classification and relationships of induced chromosomal structual changes.
Savage, J. R. (1976) · Journal of Medical Genetics · doi:10.1136/jmg.13.2.103 · Cited by 461
Small peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434
Collins, K. D., & Stark, G. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34156-0 · Cited by 424
Huang, L. C., Clarkin, K. C., & Wahl, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4827 · Cited by 384
Self-citationThe ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes.
Marechal, V, Elenbaas, B., Piette, J., Nicolas, J. C., & Levine, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7414 · Cited by 318
Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y., Bradley, A., Li, W., Bertino, J. R., & Wahl, G. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5436 · Cited by 296
Self-citationSkoog, L., & NordenskjÖLD, B. (1971) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1971.tb01290.x · Cited by 276
Windle, B., Draper, B. W., Yin, Y. X., O'Gorman, S., & Wahl, G. M. (1991) · Genes & Development · doi:10.1101/gad.5.2.160 · Cited by 242
Self-citationHalbert, C. L., Demers, G. W., & Galloway, D. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2125-2134.1992 · Cited by 227
Dbaibo, G. S., Pushkareva, M. Y., Jayadev, S., Schwarz, J. K., Horowitz, J. M., Obeid, L. M., & Hannun, Y. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1347 · Cited by 226
Ma, C., Martin, S., Trask, B., & Hamlin, J. L. (1993) · Genes & Development · doi:10.1101/gad.7.4.605 · Cited by 192
Nucleotide Metabolism: An Introduction
Henderson, J. F., & Paterson, A. R. P. (1973) · Cited by 169
High-pressure liquid chromatography-ultraviolet analysis of intracellular nucleotides
Pogolotti, A. L., & Santi, D. V. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90524-3 · Cited by 157
The role of E2F in the mammalian cell cycle
Farnham, P., Slansky, J. E., & Kollamar, R. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90001-s · Cited by 134
Li, W., Fan, J., Hochhauser, D., Banerjee, D., Zieliński, Z., Almasan, A., Yin, Y., Kelly, R., Wahl, G. M., & Bertino, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10436 · Cited by 108
Self-citationClinical, biological, and biochemical effect of pyrazofurin.
Cadman, E. C., Dix, D. E., & Handschumacher, R. E. (1978) · PubMed · Cited by 104
p53 Is Covalently Linked to 5.8S rRNA
Fontoura, B. M. A., Sorokina, E. A., David, E., & Carroll, R. B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5145 · Cited by 101
(1973) · The Enzymes · doi:10.1016/s1874-6047(08)60119-5 · Cited by 96
Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration.
Sherley, J. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54302-7 · Cited by 94
Genetic instability as a consequence of inappropriate entry into and Progression through S-phase
Almasan, A., Linke, S. P., Paulson, T. G., Huang, L.-C., & Wahl, G. M. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690212 · Cited by 91
Self-citationTelomeric and Nontelomeric (TTAGGG)n Sequences in Gene Amplification and Chromosome Stability
Bertoni, L., Attolini, C., Tessera, L., et al. (1994) · Genomics · doi:10.1006/geno.1994.1581 · Cited by 88
Kuo, M. T., Vyas, R. C., Jiang, L.-X., & Hittelman, W. N. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5202-5211.1994 · Cited by 81
Gale, G. R., & Schmidt, G. B. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90246-3 · Cited by 46
p53-dependent growth arrest of REF52 cells containing newly amplified DNA.
Ishizaka, Y., Chernov, M. V., Burns, C. M., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3224 · Cited by 38
Moyer, J. D., Smith, P. A., Levy, E. J., & Handschumacher, R. E. (1982) · PubMed · Cited by 33
Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin
Cadman, E. C., & Benz, C. C. (1980) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(80)90111-2 · Cited by 28
Cell Cycle Regulation of Gene AmplificationPreprint
Leonardo, A. D., Linke, S. P., Yin, Y., & Wahl, G. M. (1993) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1993.058.01.073 · Cited by 26
Self-citationDNA topoisomerase II inhibition and gene amplification in V79/B7 cells
Leonardo, A. D., Cavolina, P., & Maddalena, A. (1993) · Mutation Research Letters · doi:10.1016/0165-7992(93)90075-7 · Cited by 10
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90516-z · Cited by 2
Cited by
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
Metadata
- Authors
- Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A., & Wahl, G. M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1996-04-15
- Volume
- 10
- Issue
- 8
- Pages
- 934-947
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2021491682
- Cited by
- 538
- References
- 50
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.